A detailed history of Bristol John W & CO Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bristol John W & CO Inc holds 1,685 shares of MRK stock, worth $170,471. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,685
Holding current value
$170,471
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $208,603 - $224,037
1,685 New
1,685 $208,000
Q2 2023

Jul 28, 2023

SELL
$108.61 - $118.38 $1.12 Million - $1.22 Million
-10,334 Reduced 43.36%
13,500 $1.56 Million
Q4 2022

Jan 17, 2023

SELL
$87.44 - $112.11 $10,842 - $13,901
-124 Reduced 0.52%
23,834 $0
Q3 2022

Oct 31, 2022

BUY
$84.53 - $94.96 $10,481 - $11,775
124 Added 0.52%
23,958 $2.06 Million
Q1 2021

Apr 27, 2021

BUY
$68.86 - $81.11 $929,610 - $1.09 Million
13,500 Added 130.64%
23,834 $1.84 Million
Q3 2020

Oct 26, 2020

BUY
$73.18 - $82.95 $756,242 - $857,205
10,334 New
10,334 $857,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $256B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Bristol John W & CO Inc Portfolio

Follow Bristol John W & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bristol John W & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bristol John W & CO Inc with notifications on news.